4 ms·
Do they need to collect this information in the first place?
by crispyporkbites 6y ago
Do they need to collect this information in the first place?
- rad_gruchalski 6y agoIs it being collected?
- consp 6y agoYes, you want to contact them if some issue comes up which was not immediately clear.
- La1n 6y agoPfizer should not have this data, normally it doesn't leave the investigation site. Pfizer has only coded data (pseudoanonymous) that does have subject names replaced with numbers. edit: note that subjects can still be identified with this data, just not directly.
- mc32 6y agoCROs handle that data. Also adverse effects are strictly handled by third parties. This is likely an attempt at IP theft. Probably a second rate state actor.
- mft_ 6y agoCROs act as an agent of the Pharma company, so shouldn’t have it either. Patient identifiable information shouldn’t leave the investigator’s site.
- ekianjo 6y agoNo, there should be no reason for Pfizer to collect this data. This could be done by a third party.